Exscientia
develops an AI-based platform that enables to design and develop small molecule drugs... Read moreExscientia
develops an AI-based platform that enables to design and develop small molecule drugs... Read more
Founder & CEO
Andrew Hopkins
News
Aug 14, 2019
Techworld
Exscientia: Exscientia CEO explains how AI is transforming drug discovery
Aug 05, 2019
PharmiWeb
Exscientia: Sanofi exercises Option on Exscientia-designed Bispecific Small Molecule for treatment of immunological conditions
Jul 25, 2019
FE Investegate
Exscientia: Frontier IP Group : Exscientia collaboration with Rallybio
Apr 05, 2019
BioPortfolio
Exscientia: AI drug development partnership between GlaxoSmithKline Exscientia yields first drug candidate
Mar 29, 2019
BioPortfolio
Exscientia: Celgene and Exscientia sign $25 million AI drug discovery deal
Mar 28, 2019
Pharamceutical Technology
Exscientia: Exscientia's partnership spree continues with $25m Celgene deal
Mar 25, 2019
Contract Pharma
Exscientia: Exscientia Launches New Subsidiary
Mar 21, 2019
The Pharma Letter
Exscientia: Celgene pays $25 million to become latest pharma to partner with Exscientia
Nov 15, 2018
PMLiVE
Exscientia: AI specialist Exscientia buys Kinetic Discovery
Oct 06, 2018
BioPortfolio
Exscientia: Ex Scientia Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Exscientia Competitors
1
2
3
4
5
6
7
8
9
10